---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-000395"
form_type: "8-K"
ticker: "KZR"
cik: "0001645666"
company_name: "Kezar Life Sciences, Inc."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:54:22.650891+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Kezar Life Sciences reports preliminary cash of $276.6M and 68.5M shares outstanding as of Dec 31, 2022

## Summary
- Preliminary cash, cash equivalents and marketable securities of ~$276.6M as of Dec 31, 2022.
- Approximately 68.5 million shares of common stock outstanding as of year-end 2022.
- Estimates are unaudited and subject to change upon completion of year-end closing procedures.

## SEC filing metadata
- accession: 0000950170-23-000395
- form_type: 8-K
- ticker: KZR
- cik: 0001645666
- company_name: Kezar Life Sciences, Inc.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645666/000095017023000395/0000950170-23-000395-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645666/000095017023000395/kzr-20230109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-000395
- JSON: https://secwatch.observer/filing/0000950170-23-000395.json
- Plain text: https://secwatch.observer/filing/0000950170-23-000395.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.